Application of hemopoietic growth factors in MDS.
Growth factors offer a new strategy in the treatment of MDS. Their favorable effect in the treatment of diseases related to previous therapy is well known. The evaluation of the influence of these factors on the total survival time requires further controlled investigations. Longer observation of a more numerous group of patients will enable us to show whether growth factors therapy significantly decreases the number of infections and letters the quality of life. To sum up, growth factors markedly improve the result of treatment of neoplasms.
Hoelzer
D
D
Dept. of Hematology/Onkology, University of Frankfurt.
D016298:Hematopoietic Cell Growth Factors / Q000627:therapeutic use*; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000628:therapy*
D016298:Hematopoietic Cell Growth Factors